113
Views
13
CrossRef citations to date
0
Altmetric
Theme: Gynecologic - Review

Intraoperative lymphatic mapping techniques for endometrial cancer

, , , , &
Pages 83-93 | Published online: 10 Jan 2014

References

  • Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J. Clin.60(5), 277–300 (2010).
  • Fanning J, Evans MC, Peters AJ, Samuel M, Harmon ER, Bates JS. Endometrial adenocarcinoma histologic subtypes: clinical and pathologic profile. Gynecol. Oncol.32(3), 288–291 (1989).
  • Bakkum-Gamez JN, Gonzalez-Bosquet J, Laack NN, Mariani A, Dowdy SC. Current issues in the management of endometrial cancer. Mayo Clin. Proc.83(1), 97–112 (2008).
  • Santin AD, Bellone S, O’Brien TJ, Pecorelli S, Cannon MJ, Roman JJ. Current treatment options for endometrial cancer. Expert Rev. Anticancer Ther.4(4), 679–689 (2004).
  • Hamilton CA, Cheung MK, Osann K et al. Uterine papillary serous and clear cell carcinomas predict for poorer survival compared with grade 3 endometrioid corpus cancers. Br. J. Cancer94(5), 642–646 (2006).
  • Mourits MJ, Bijen CB, Arts HJ et al. Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial. Lancet Oncol.11(8), 763–771 (2010)
  • Cardenas-Goicoechea J, Adams S, Bhat SB, Randall TC. Surgical outcomes of robotic-assisted surgical staging for endometrial cancer are equivalent to traditional laparoscopic staging at a minimally invasive surgical center. Gynecol. Oncol.117(2), 224–228 (2010).
  • Frumovitz M, Gershenson DM. Fertility-sparing therapy for young women with endometrial cancer. Expert Rev. Anticancer Ther.6(1), 27–32 (2006).
  • Fiorelli JL, Herzog TJ, Wright JD. Current treatment strategies for endometrial cancer. Expert Rev. Anticancer Ther.8(7), 1149–1157 (2008).
  • Creasman WT, Morrow CP, Bundy BN et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group study. Cancer60(8 Suppl.), 2035–2041 (1987).
  • Creasman WT, Odicino F, Maisonneuve P et al. Carcinoma of the corpus uteri. J. Epidemiol. Biostat.6(1), 47–86 (2001).
  • Odicino F, Pecorelli S, Zigliani L, Creasman WT. History of the FIGO cancer staging system. Int. J. Gynaecol. Obstet.101(2), 205–210 (2008).
  • Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int. J. Gynaecol. Obstet.105(2), 109 (2009).
  • Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int. J. Gynaecol. Obstet.105(2), 103–104 (2009).
  • Mariani A, Dowdy SC, Podratz KC. New surgical staging of endometrial cancer: 20 years later. Int. J. Gynaecol. Obstet.105(2), 110–111 (2009).
  • Mariani A, Dowdy SC, Cliby WA et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol. Oncol.109(1), 11–18 (2008).
  • Yoon JH, Yoo SC, Kim WY, Chang SJ, Chang KH, Ryu HS. Para-aortic lymphadenectomy in the management of preoperative grade 1 endometrial cancer confined to the uterine corpus. Ann. Surg. Oncol.DOI: 10.1245/s10434-010-1199-1195 (2010) (Epub ahead of print).
  • Kilgore LC, Partridge EE, Alvarez RD et al. Adenocarcinoma of the endometrium: survival comparison of patients with and without pelvis node sampling. Gynecol. Oncol.56(1), 29–33 (1995).
  • May K, Bryant A, Dickinson HO, Kehoe S, Morrison J. Lymphadenectomy for the management of endometrial cancer. Cochrane Database Syst. Rev.1, CD007585 (2010).
  • Benedetti Panici P, Basile S, Maneschi F et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J. Natl Cancer Inst.100(23), 1707–1716 (2008).
  • ASTEC study group, Kitchener H, Swart AM, Qian Q, Amos C, Parmar MK. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet373(9658), 125–136 (2009).
  • Uccella S, Podratz KC, Aletti GD, Mariani A. Re: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J. Natl Cancer Inst.101(12), 897–898 (2009).
  • Creasman WT, Mutch DE, Herzog TJ. ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? Gynecol. Oncol.116(3), 293–294 (2010).
  • Kwon JS, Qiu F, Saskin R, Carey MS. Are uterine risk factors more important than nodal status in predicting survival in endometrial cancer? Obstet. Gynecol.114(4), 736–743 (2009).
  • Oonk MHM, van de Nieuwenhof HP, van der Zee AGJ, de Hullu JA. Update on the sentinel lymph node procedure in vulvar cancer. Expert Rev. Anticancer Ther.10(1), 61–69 (2010).
  • Gould EA, Winship T, Philbin PH, Kerr H. Observations on a “sentinel node” in the parotid. Cancer13, 77–78 (1960).
  • Van der Zee AG, Oonk MH, de Hullu JA et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J. Clin. Oncol.26(6), 884–889 (2008).
  • Kara PP, Ayahan A, Caner B et al. Analysis of dendritic cells in sentinel lymph nodes of patients with endometrial and patients with cervical cancers. Int. J. Gynecol. Cancer19(7), 1239–1243 (2009).
  • Quan ML, McCready D. The evolution of lymph node assessment in breast cancer. J. Surg. Oncol.99(4), 194–198 (2009).
  • Stadelmann WK. The role of lymphatic mapping and sentinel lymph node biopsy in the staging and treatment of melanoma. Clin. Plast. Surg.37(1), 79–99 (2010).
  • Gortzak-Uzan L, Jimenez W, Nofech-Mozes S et al. Sentinel lymph node biopsy vs. pelvic lymphadenectomy in early stage cervical cancer: is it time to change the gold standard? Gynecol. Oncol.116(1), 28–32 (2010).
  • Fader AN, Edwards RP, Cost M et al. Sentinel lymph node biopsy in early-stage cervical cancer: utility of intraoperative versus postoperative assessment. Gynecol. Oncol.111(1), 13–17 (2008).
  • Marchiolè P, Buenerd A, Scoazec JY, Dargent D, Mathevet P. Sentinel lymph node biopsy is not accurate in predicting lymph node status for patients with cervical carcinoma. Cancer100(10), 2154–2159 (2004).
  • El-Ghobashy AE, Saidi SA. Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications. Eur. J. Surg. Oncol.35(7), 675–685 (2009).
  • Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. Gynecol. Oncol.62(2), 169–173 (1996).
  • Frumovitz M, Bodurka DC, Broaddus RR et al. Lymphatic mapping and sentinel node biopsy in women with high-risk endometrial cancer. Gynecol. Oncol.104(1), 100–103 (2007).
  • Echt ML, Finan MA, Hoffman MS, Kline RC, Roberts WS, Fiorica JV. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South. Med. J.92(2), 204–208 (1999).
  • Holub Z, Jabor A, Kliment L. Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: a pilot study. Eur. J. Gynaecol. Oncol.23(1), 53–57 (2002).
  • Gien LT, Kwon JS, Carey MS. Sentinel node mapping with isosulfan blue dye in endometrial cancer. J. Obstet. Gynaecol. Can.27(12), 1107–1112 (2005).
  • Altgassen C, Pagenstecher J, Hornung D, Diedrich K, Hornemann A. A new approach to label sentinel nodes in endometrial cancer. Gynecol. Oncol.105, 457–461 (2007).
  • Li B, Li XG, Wu LY et al. A pilot study of sentinel lymph nodes identification in patients with endometrial cancer. Bull. Cancer94(1), E1–E4 (2007).
  • Lopes LA, Nicolau SM, Baracat FF et al. Sentinel lymph node in endometrial cancer. Int. J. Gynecol. Cancer17(5), 1113–1117 (2007).
  • Niikura H, Okamura C, Utsunomiya H et al. Sentinel lymph node detection in patients with endometrial cancer. Gynecol. Oncol.92(2), 669–674 (2004).
  • Fersis N, Gruber I, Relakis K et al. Sentinel node identification and intraoperative lymphatic mapping. First results of a pilot study in patients with endometrial cancer. Eur. J. Gynaecol. Oncol.25(3), 339–342 (2004).
  • Vidal-Sicart S, Doménech B, Lujan B et al. Sentinel node in gynecological cancers. Our experience. Rev. Esp. Med. Nucl.28(5), 221–228 (2009).
  • Feranec R, Mouková L, Stanícek J, Stefániková L, Chovanec J. Sentinel lymph node identification using hysteroscopy in patients with endometrial cancer. Klin. Onkol.23(2), 92–98 (2010).
  • Pelosi E, Arena V, Baudino B et al. Preliminary study of sentinel node identification with 99mTc colloid and blue dye in patients with endometrial cancer. Tumori88(3), S9–S10 (2002).
  • Gargiulo T, Giusti M, Bottero M et al. Sentinel lymph node (SLN) laparoscopic assessment in early stage endometrial cancer. Minerva Gynecol.55(3), 259–262 (2003).
  • Pelosi E, Arena V, Baudino B et al. Pre-operative lymphatic mapping and intra-operative sentinel lymph node detection in early stage endometrial cancer. Nucl. Med. Commun.24(9), 971–975 (2003).
  • Barranger E, Cortez A, Grahek D, Callard P, Uzan S, Darai E. Laparoscopic sentinel node procedure using a combination of patent blue and radiocolloid in women with endometrial cancer. Ann. Surg. Oncol.11(3), 344–349 (2004).
  • Lelievre L, Camatte S, Le Frere-Belda MA et al. Sentinel lymph node biopsy in cervix and corpus uteri cancers. Int. J. Gynecol. Cancer14(2), 271–278 (2004).
  • Raspagliesi F, Ditto A, Kusamura S et al. Hysteroscopic injection of tracers in sentinel node detection of endometrial cancer: a feasibility study. Am. J. Obstet. Gynecol.191(2), 435–439 (2004).
  • Maccauro M, Lucignani G, Aliberti G et al. Sentinel lymph node detection following the hysteroscopic peritumoral injection of 99mTc-labelled albumin nanocolloid in endometrial cancer. Eur. J. Nucl. Med. Mol. Imaging32(5), 569–574 (2005).
  • Bats AS, Clément D, Larousserie F et al. Is sentinel node biopsy feasible in endometrial cancer? Results in 26 patients. J. Gynecol. Obstet. Biol. Reprod. (Paris)34(5), 768–774 (2005).
  • Depelch Y, Cortez A, Coutant C et al. The sentinel concept in endometrial cancer: histopatologic validation by serial section and immunohistochemistry. Ann. Oncol.18(11), 1799–1803 (2007).
  • Bats AS, Clément D, Larousserie F et al. Does sentinel node biopsy improve the management of endometrial cancer? Data from 43 patients. J. Surg. Oncol.97(2), 141–145 (2008).
  • Ballester M, Dubernard G, Rouzier R, Barranger E, Darai E. Use of the sentinel node procedure to stage endometrial cancer. Ann. Surg. Oncol.15(5), 1523–1529 (2008).
  • Barranger E, Depelch Y, Coutant C, Dubernard G, Uzan S, Darai E. Laparoscopic sentinel node mapping using combined detection for endometrial cancer: a study of 33 cases – is it a promising technique? Am. J. Surg.197(1), 1–7 (2009).
  • Abu-Rustum NR, Khoury-Collado F, Pandit-Taskar N et al. Sentinel node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma? Gynecol. Oncol.113(2), 163–169 (2009).
  • Khoury-Collado F, Glaser GE, Zivanovic O et al. Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed? Gynecol. Oncol.115(3), 453–455 (2009).
  • Delaloye JF, Pampallona S, Chardonnens E et al. Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol. Oncol.106(1), 89–93 (2007).
  • Perrone AM, Casadio P, Formelli G et al. Cervical and hysteroscopic injection for identification of sentinel lymph node in endometrial cancer. Gynecol. Oncol.111(1), 62–67 (2008).
  • Robova H, Charvat M, Strnad P et al. Lymphatic mapping in endometrial cancer: comparison of hysteroscopic and subserosal injection and the distribution of sentinel lymph nodes. Int. J. Gynecol. Cancer19(3), 391–394 (2009).
  • Mais V, Peiretti M, Gargiulo T, Parodo G, Cirronis MG, Melis GB. Intraoperative sentinel lymph node detection by vital die through laparoscopy or laparotomy in early endometrial cancer. J. Surg. Oncol.101(5), 408–412 (2010).
  • Ballester M, Rouzier R, Coutant C, Kerrou K, Darai E. Limits of lymhoscintigraphy for sentinel node biopsy in women with endometrial cancer. Gynecol. Oncol.112(2), 348–352 (2009).
  • Niikura H, Okamoto S, Yoshinaga K et al. Detection of micrometastases in the sentinel lymph nodes of patients with endometrial camcer. Gynecol. Oncol.105(3), 683–686 (2007).
  • Levenback CF, van der Zee AG, Rob L et al. Sentinel lymph node biopsy in patients with gynecologic cancers: expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol. Oncol.114(2), 151–156 (2009).
  • Ballester M, Koskas M, Coutant C et al. Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy? BMC Cancer10(1), 465 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.